Zhongnan Hospital
Clinical trials sponsored by Zhongnan Hospital, explained in plain language.
-
New hope for advanced cervical cancer: drug combo targets tumors that standard chemo can't stop
Disease control Not yet recruitingThis study tests a combination of two drugs—Utidelone and Toripalimab—in people with recurrent or metastatic cervical cancer that has progressed after standard chemotherapy. About 32 participants will receive both drugs intravenously in 21-day cycles. The goal is to see if the tr…
Phase: PHASE2 • Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated May 01, 2026 19:12 UTC
-
New drug cocktail aims to make liver tumors removable in colon cancer patients
Disease control Not yet recruitingThis study tests a chemotherapy regimen called FULIRI combined with targeted therapy (bevacizumab or cetuximab) as a first treatment for people with colorectal cancer that has spread to the liver. The goal is to shrink the liver tumors enough so they can be surgically removed or …
Phase: PHASE2 • Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
New dual-target PET probe aims to sharpen cancer imaging
Diagnosis Not yet recruitingThis study tests a new radioactive imaging agent called 68Ga-B6FA-01, designed to make PET/CT scans more accurate for detecting and staging solid tumors. The probe targets two different markers found on cancer cells and their surroundings, which may improve image clarity. About 1…
Sponsor: Zhongnan Hospital • Aim: Diagnosis
Last updated Apr 29, 2026 15:05 UTC
-
New PET probe aims to light up hidden tumors
Diagnosis Not yet recruitingThis study tests a new imaging agent called 68Ga-SFB6-ZN01 that attaches to a protein found on many cancer cells. About 98 adults with known or suspected cancer will receive one injection and have a PET/CT scan. The goal is to see if the agent is safe and can accurately detect tu…
Phase: EARLY_PHASE1 • Sponsor: Zhongnan Hospital • Aim: Diagnosis
Last updated Apr 26, 2026 20:01 UTC